October 21, 2013 3:23 am
MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ – Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir). Levemir® FlexTouch® has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes).
The approval was also announced at the 2013 Vascular Conference in Montreal, Quebec.
Health Canada approves Levemir® FlexTouch® prefilled insulin pen for the treatment of type 1 and type 2 diabetes
http://www.pharmalive.com/health-canada-approves-levemir-flextouch
Posted by DR ANTHONY MELVIN CRASTO Ph.D
Categories: canada
Tags: Anthony crasto, drugs, fda, insulin, Levemir, medicinal chemistry, organic chemistry, PROCESS, world drug tracker
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.
Reblogged this on MedChemHot.Pakistan.
LikeLike
By suraiyahaider on October 22, 2013 at 1:02 am
Is this levemir have cartridge facility. Give navi Mumbai or dombivaly agent name and number.
LikeLike
By sunitha on August 19, 2015 at 6:32 am